- Corporate Officers - S
- Steinman Lawrence
Insider Trading History of Steinman Lawrence
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Steinman Lawrence since 2021.
This trader's CIK number is 1132679.
At the time of last reporting, Steinman Lawrence was the Director of Bioatla, Inc.. (stock ticker symbol BCAB).
Also see all insider trading activities at Bioatla, Inc..
Note that in the past
STEINMAN LAWRENCE also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Pasithea Therapeutics Corp. (KTTA) by Steinman Lawrence
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | KTTA | 30,000 | $12,930 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Bioatla, Inc. (BCAB) by Steinman Lawrence
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | BCAB | 20,000 | $41,040 | 0 | $0 | 0 | $0 |
| 2021 | BCAB | 0 | $0 | 1,800 | $65,569 | 0 | $0 |
Yearly summary of insider trading at 180 Life Sciences Corp. (ATNF) by Steinman Lawrence
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2023 | ATNF | 18,000 | $22,068 | 0 | $0 | 0 | $0 |
| 2021 | ATNF | 5,000 | $21,349 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Steinman Lawrence:
1. Pasithea Therapeutics Corp. (KTTA)
2. Bioatla, Inc. (BCAB)
3. 180 Life Sciences Corp. (ATNF)
Table 1. Insider trading of Pasithea Therapeutics Corp. (KTTA) by Steinman Lawrence
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-02 | KTTA | Buy | 30,000 | .43 | 12,930 |
Table 2. Insider trading of Bioatla, Inc. (BCAB) by Steinman Lawrence
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-12-19 | BCAB | Buy | 20,000 | 2.05 | 41,040 |
| 2021-11-02 | BCAB | Sale | 450 | 30.00 | 13,500 |
| 2021-09-15 | BCAB | Sale | 450 | 36.82 | 16,569 |
| 2021-08-16 | BCAB | Sale | 450 | 40.60 | 18,270 |
| 2021-07-15 | BCAB | Sale | 450 | 38.29 | 17,230 |
Table 3. Insider trading of 180 Life Sciences Corp. (ATNF) by Steinman Lawrence
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2023-06-01 | ATNF | Buy | 18,000 | 1.23 | 22,068 |
| 2021-12-09 | ATNF | Buy | 5,000 | 4.27 | 21,349 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Steinman Lawrence
(Director of Bioatla, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.